A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer
I4T-MC-JVDU - ClinicalTrials.gov - NCT04557384
The purpose of this study in participants with advanced cancer is to learn more about the safety of ramucirumab when given by injection under the skin (subcutaneous injection).
Trial Summary
Age Range
≥18 yearsConditions the trial is for
What the trial is testing?
Could I receive a Placebo?
NoEnrollment Goal
3Trial Dates
Feb 23, 2021 - May 25, 2021How long will I be in the trial?
Your participation in this trial could last up to 24 months, depending on your cancer type and how you and your tumor respond.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo